Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Malignant Lymphoma

Free Subscription 21.01.2019 1 Blood 1 Cancer Res 2 Haematologica 1 Lancet Oncol 10 Leuk Lymphoma 1 Leukemia

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Blood

1. MATSUE K, Abe Y, Kitadate A, Miura D, et al
   Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma.
   Blood. 2019 Jan 15. pii: blood-2018-11-887570. doi: 10.1182/blood-2018-11-887570
   PubMed     Text format    
   
   

   
   Cancer Res

2. TAYLOR A, Rothstein D, Rudd CE
   Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy.
   Cancer Res. 2018;78:706-717.
   PubMed     Text format     Abstract available
   
   

   
   Haematologica

3. QDAISAT A, Al Soud R, Wu CC, Rojas Hernandez CM, et al
   Poor performance of D-Dimer in excluding venous thromboembolism among patients with lymphoma and leukemia.
   Haematologica. 2019 Jan 10. pii: haematol.2018.211466.
   PubMed     Text format    
   
   
4. TAKEUCHI M, Miyoshi H, Asano N, Yoshida N, et al
   Human leukocyte antigen class II expression is a good prognostic factor of adult T-cell leukemia/lymphoma.
   Haematologica. 2019 Jan 10. pii: haematol.2018.205567.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Oncol

5. BROMBERG JEC, Issa S, Bakunina K, Minnema MC, et al
   Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
   Lancet Oncol. 2019 Jan 7. pii: S1470-2045(18)30747.
   PubMed     Text format     Abstract available
   
   

   
   Leuk Lymphoma

6. BOHN JP, Willenbacher W, Haas G, Peschel I, et al
   Pomalidomide in primary intraocular lymphoma.
   Leuk Lymphoma. 2019 Jan 11:1-3. doi: 10.1080/10428194.2018.1538508.
   PubMed     Text format    
   
   
7. RITTER AJ, Goldstein JS, Ayers AA, Flowers CR, et al
   Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study.
   Leuk Lymphoma. 2019 Jan 11:1-12. doi: 10.1080/10428194.2018.1546855.
   PubMed     Text format     Abstract available
   
   
8. JANIGA J, Kentley J, Nabhan C, Abdulla F, et al
   Current systemic therapeutic options for advanced mycosis fungoides and Sezary syndrome.
   Leuk Lymphoma. 2018;59:562-577.
   PubMed     Text format     Abstract available
   
   
9. FRICK M, Bettstetter M, Bertz S, Schwarz-Furlan S, et al
   Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL.
   Leuk Lymphoma. 2018;59:1260-1263.
   PubMed     Text format    
   
   
10. GUZAUSKAS GF, Masaquel A, Thuresson PO, Dawson K, et al
    Obinutuzumab plus chemotherapy followed by obinutuzumab monotherapy is cost-effective vs. rituximab plus chemotherapy followed by rituximab monotherapy for previously untreated follicular lymphoma patients in the United States.
    Leuk Lymphoma. 2019 Jan 11:1-9. doi: 10.1080/10428194.2018.1551532.
    PubMed     Text format     Abstract available
    
    
11. ANSELL SM
    Immunophenotype switching in cutaneous T-cell lymphoma: nature or nurture?
    Leuk Lymphoma. 2019 Jan 11:1-2. doi: 10.1080/10428194.2018.1543887.
    PubMed     Text format    
    
    
12. CHEN SH, Chen JS, Jou ST, Wu KH, et al
    Outcome and prognosis of anaplastic large cell lymphoma in children: a report from the Taiwan Pediatric Oncology Group.
    Leuk Lymphoma. 2019 Jan 15:1-8. doi: 10.1080/10428194.2018.1562182.
    PubMed     Text format     Abstract available
    
    
13. WANG XX, Li PF, Bai B, Gao Y, et al
    Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol.
    Leuk Lymphoma. 2019 Jan 16:1-9. doi: 10.1080/10428194.2018.1563690.
    PubMed     Text format     Abstract available
    
    
14. PATHAK P, Perimbeti S, Ames A, Moskowitz AJ, et al
    Guillain Barre syndrome heralding the diagnosis of angioimmunoblastic T-cell lymphoma.
    Leuk Lymphoma. 2019 Jan 16:1-4. doi: 10.1080/10428194.2018.1553299.
    PubMed     Text format    
    
    
15. NEVEL KS, Pentsova E, Daras M
    Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphoma.
    Leuk Lymphoma. 2019 Jan 16:1-8. doi: 10.1080/10428194.2018.1551541.
    PubMed     Text format     Abstract available
    
    

    
    Leukemia

16. DODERO A, Guidetti A, Tucci A, Barretta F, et al
    Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma.
    Leukemia. 2019 Jan 10. pii: 10.1038/s41375-018-0320.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: